• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环活化蛋白C水平低是静脉血栓栓塞的一个危险因素。

Low level of circulating activated protein C is a risk factor for venous thromboembolism.

作者信息

España F, Vayá A, Mira Y, Medina P, Estellés A, Villa P, Falcó C, Aznar J

机构信息

Research Center, La Fe University Hospital, Valencia, Spain.

出版信息

Thromb Haemost. 2001 Dec;86(6):1368-73.

PMID:11776301
Abstract

The levels of circulating activated protein C (APC) reflect in vivo protein C activation. The aim of this study was to determine whether a low APC level is an independent risk factor for venous thromboembolism (VTE). We measured APC in 160 patients with a history of VTE and without recognized thrombophilic defects, and in 199 healthy individuals. The mean (+/- SD) APC level was lower in patients (0.99 +/- 0.44 ng/ml) than in controls (1.19 +/- 0.41 ng/ml) (p < 0.0001), and showed a different distribution in the two groups. Thirty-eight patients (23.7%) had APC levels below the 5th percentile of the control group (<0.69 ng/ml) and 57 patients (35.6%) had APC levels below the 10th percentile (<0.77 ng/ml). APC levels <0.69 ng/ml increased the risk of a single or recurrent episode of VTE 4.2-fold (95% confidence interval, 2.0-9.0) or 6.9-fold (2.6-17.9). respectively, and APC levels <0.77 ng/ml increased these risks 3.4-fold (1.9-6.2) or 5.1-fold (2.3-11.2), respectively, compared with controls. Familial studies revealed that in some cases the low APC phenotype seems to be hereditary. We conclude that a low level of circulating APC in individuals without any of the most recognized thrombophilic defects is a prevalent, independent risk factor for VTE, and that it predisposes to recurrent VTE.

摘要

循环活化蛋白C(APC)水平反映体内蛋白C的活化情况。本研究旨在确定低APC水平是否为静脉血栓栓塞症(VTE)的独立危险因素。我们检测了160例有VTE病史且无公认血栓形成倾向缺陷的患者以及199名健康个体的APC水平。患者的平均(±标准差)APC水平(0.99±0.44 ng/ml)低于对照组(1.19±0.41 ng/ml)(p<0.0001),且两组的分布不同。38例患者(23.7%)的APC水平低于对照组的第5百分位数(<0.69 ng/ml),57例患者(35.6%)的APC水平低于第10百分位数(<0.77 ng/ml)。与对照组相比,APC水平<0.69 ng/ml使单次或复发性VTE发作的风险分别增加4.2倍(95%置信区间,2.0 - 9.0)或6.9倍(2.6 - 17.9),APC水平<0.77 ng/ml使这些风险分别增加3.4倍(1.9 - 6.2)或5.1倍(2.3 - 11.2)。家族研究表明,在某些情况下,低APC表型似乎具有遗传性。我们得出结论,在没有任何最公认的血栓形成倾向缺陷的个体中,循环APC水平低是VTE的一个普遍存在的独立危险因素,且易导致复发性VTE。

相似文献

1
Low level of circulating activated protein C is a risk factor for venous thromboembolism.循环活化蛋白C水平低是静脉血栓栓塞的一个危险因素。
Thromb Haemost. 2001 Dec;86(6):1368-73.
2
Activated protein C levels in Behçet's disease and risk of venous thrombosis.白塞病中活化蛋白C水平与静脉血栓形成风险
Br J Haematol. 2004 Aug;126(4):550-6. doi: 10.1111/j.1365-2141.2004.05072.x.
3
Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
Thromb Haemost. 1996 Jan;75(1):56-61.
4
Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.因子V莱顿突变携带者及无已知血栓形成风险因素患者的静脉血栓栓塞;复发预测以及活化蛋白C-蛋白C抑制物复合物浓度和/或可溶性血栓调节蛋白抗原及活性
Thromb Res. 2007;121(2):145-51. doi: 10.1016/j.thromres.2007.03.020. Epub 2007 May 11.
5
[Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women].[绝经后女性中与活化蛋白C表型抵抗相关的血栓形成倾向综合征]
Minerva Ginecol. 2004 Apr;56(2):131-6.
6
High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.患有蛋白S、蛋白C或抗凝血酶遗传性缺陷的患者,复发性静脉血栓栓塞的长期绝对风险较高。
Thromb Haemost. 2009 Jan;101(1):93-9.
7
Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.静脉血栓形成的遗传和获得性危险因素对基于凝血酶生成的活化蛋白C抵抗试验的影响。
Thromb Haemost. 2002 Jul;88(1):5-11.
8
Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia.不明原因血栓形成倾向家族中凝血和纤维蛋白溶解的评估。
Thromb Haemost. 2009 Mar;101(3):465-70.
9
Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.接受标准化抗凝治疗的患者的血栓形成倾向异常与静脉血栓栓塞复发
Thromb Res. 2005;116(4):301-6. doi: 10.1016/j.thromres.2004.12.012. Epub 2005 Jan 26.
10
Circulating P-selectin and the risk of recurrent venous thromboembolism.循环中的P选择素与复发性静脉血栓栓塞的风险
Thromb Haemost. 2007 Jun;97(6):880-3.

引用本文的文献

1
Carbon Nanofiber-Ionic Liquid Nanocomposite Modified Aptasensors Developed for Electrochemical Investigation of Interaction of Aptamer/Aptamer-Antisense Pair with Activated Protein C.碳纤维纳米纤维-离子液体纳米复合材料修饰适体传感器的电化学研究进展,用于研究适体/适体-反义寡核苷酸与活化蛋白 C 的相互作用。
Biosensors (Basel). 2023 Apr 4;13(4):458. doi: 10.3390/bios13040458.
2
An Exploratory Study Using Next-Generation Sequencing to Identify Prothrombotic Variants in Patients with Cerebral Vein Thrombosis.利用下一代测序技术鉴定脑静脉血栓形成患者的易栓症变异的探索性研究。
Int J Mol Sci. 2023 Apr 28;24(9):7976. doi: 10.3390/ijms24097976.
3
A Series of 14 Polish Patients with Thrombotic Events and PC Deficiency-Novel c.401-1G>A PROC Gene Splice Site Mutation in a Patient with Aneurysms.
波兰 14 例血栓事件和 PC 缺乏症患者系列报道-动脉瘤患者中发现新型 c.401-1G>A PROC 基因剪接位点突变。
Genes (Basel). 2022 Apr 22;13(5):733. doi: 10.3390/genes13050733.
4
Increase of Neutrophil Activation Markers in Venous Thrombosis-Contribution of Circulating Activated Protein C.中性粒细胞活化标志物在静脉血栓形成中的增加:循环活化蛋白 C 的作用。
Int J Mol Sci. 2020 Aug 6;21(16):5651. doi: 10.3390/ijms21165651.
5
α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism.α2-巨球蛋白是活化蛋白 C 的重要体内抑制剂,低 APC:α2M 水平与静脉血栓栓塞相关。
Thromb Haemost. 2018 Apr;118(4):630-638. doi: 10.1055/s-0038-1629902. Epub 2018 Feb 15.
6
Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases.血浆鞘脂葡萄糖神经酰胺水平较低与血栓性疾病有关。
Res Pract Thromb Haemost. 2017 Jul;1(1):33-40. doi: 10.1002/rth2.12018. Epub 2017 Jun 23.
7
The Prophylaxis of Venous Thromboembolism.静脉血栓栓塞的预防
Dtsch Arztebl Int. 2016 Aug 8;113(31-32):532-8. doi: 10.3238/arztebl.2016.0532.
8
Endothelial cell protein C receptor gene 6936A/G polymorphism is associated with venous thromboembolism.内皮细胞蛋白C受体基因6936A/G多态性与静脉血栓栓塞症相关。
Exp Ther Med. 2012 Jun;3(6):989-992. doi: 10.3892/etm.2012.510. Epub 2012 Mar 12.
9
Tissue factor, blood coagulation, and beyond: an overview.组织因子、血液凝固及其他:概述
Int J Inflam. 2011;2011:367284. doi: 10.4061/2011/367284. Epub 2011 Sep 20.
10
Activated protein C plasma levels in the fasting and postprandial states among patients with previous unprovoked venous thromboembolism.既往无诱因静脉血栓栓塞症患者空腹和餐后状态下的活化蛋白 C 血浆水平。
Thromb Res. 2012 Apr;129(4):502-7. doi: 10.1016/j.thromres.2011.06.026. Epub 2011 Jul 20.